Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-11-222180
Filing Date
2011-08-15
Accepted
2011-08-15 08:01:45
Documents
4
Effectiveness Date
2011-08-15

Document Format Files

Seq Description Document Type Size
1 FORM S-8 ds8.htm S-8 64787
2 OPINION OF MCCARTER & ENGLISH, LLP dex51.htm EX-5.1 3682
3 CONSENT OF MCGLADREY & PULLEN, LLP dex231.htm EX-23.1 1637
4 CONSENT OF CATURANO & COMPANY, INC. dex232.htm EX-23.2 1966
  Complete submission text file 0001193125-11-222180.txt   73165
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-176306 | Film No.: 111033197
SIC: 2834 Pharmaceutical Preparations